Lexaria Bioscience Corp. to Webcast Live at Life Sciences Investor Forum March 26 - Seite 3
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
CONTACT: CONTACTS: Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 johnv@lifesciencesinvestorforum.com Lexaria Bioscience Corp. Chris Bunka, CEO (250) 765-6424
Lesen Sie auch
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte